Kyverna Therapeutics, Inc. (KYTX)

Latest Insider Confidence Score

2026Q1

52.8
Bullish

Company insider confidence (by quarter)

2024Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Northpond Ventures III GP, LLC Other 2,805,426 Feb 12, 2024
Northpond Ventures III, LP Other 2,805,426 Feb 12, 2024
Rubin Michael P. Other 2,805,426 Feb 12, 2024
Bain Capital Life Sciences Investors, LLC 10% Owner 2,713,868 Feb 14, 2024
Bain Capital Life Sciences III General Partner, LLC 10% Owner 2,713,868 Feb 14, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Miller Andrew Craig Director Neutral 52.5 - 0.00% ✗ -
Feb 24, 2026 Mar 4, 2026 Miller Andrew Craig Director Neutral 90.0 +11,006 100.00% ✗ -
Feb 24, 2026 Feb 26, 2026 Emany Sravan Kumar Director Neutral 90.0 +11,006 100.00% ✗ -
Feb 26, 2026 Emany Sravan Kumar Director Neutral 52.5 - 0.00% ✗ -
Feb 11, 2026 Pujols Mayobanex Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Feb 9, 2026 Feb 11, 2026 Pujols Mayobanex Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Jan 12, 2026 Jan 14, 2026 Shaw Christi Chair Neutral 90.0 +54,301 326.45% ✗ -
Dec 18, 2025 Dec 22, 2025 SEIDENBERG BETH C Director Buy 97.5 +133,333 17.72% ✗ $1000K
Dec 18, 2025 Dec 22, 2025 Westlake BioPartners Opportunity Fund I, L.P. 10% Owner Buy 97.5 +133,333 18.12% ✗ $1000K
Dec 15, 2025 Dec 17, 2025 Walker Karen Marie Chief Technology Officer Sell 7.5 -23,998 -51.46% ✓ $292.8K
Jun 30, 2025 Jul 1, 2025 GRASSO MARC CFO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 GRASSO MARC CFO Neutral 52.5 - 0.00% ✗ -
May 29, 2025 Jun 2, 2025 Shaw Christi Director Neutral 90.0 +16,634 100.00% ✗ -
May 29, 2025 Jun 2, 2025 SEIDENBERG BETH C Director Neutral 60.0 +16,634 0.37% ✗ -
May 29, 2025 Jun 2, 2025 SPIEGELMAN DANIEL K Director Neutral 90.0 +16,634 100.00% ✗ -
May 29, 2025 Jun 2, 2025 Aktar Mert Director Neutral 90.0 +16,634 100.00% ✗ -
May 29, 2025 Jun 2, 2025 CLARK IAN T Director Neutral 90.0 +16,634 100.00% ✗ -
May 29, 2025 Jun 2, 2025 Cohen Fred E Director Neutral 60.0 +16,634 0.37% ✗ -
Apr 11, 2024 Apr 15, 2025 Biddle Warner Weston CEO Neutral 52.5 - 0.00% ✗ -
Apr 11, 2025 Apr 15, 2025 Jones Ryan Alexander CFO Neutral 90.0 +12,000 27.30% ✗ -
Apr 11, 2025 Apr 15, 2025 Walker Karen Marie Chief Technology Officer Neutral 90.0 +13,000 134.91% ✗ -
Feb 14, 2025 Feb 19, 2025 Shaw Christi Director Neutral 52.5 - 0.00% ✗ -
Jan 22, 2025 Jan 24, 2025 GEHCHAN NAJI Officer Neutral 52.5 - 0.00% ✗ -
Jan 24, 2025 GEHCHAN NAJI Officer Neutral 52.5 - 0.00% ✗ -
Oct 21, 2024 Oct 24, 2024 Aktar Mert Director Neutral 52.5 - 0.00% ✗ -
Oct 24, 2024 Aktar Mert Director Neutral 52.5 - 0.00% ✗ -
Sep 16, 2024 Sep 18, 2024 Biddle Warner Weston CEO Neutral 52.5 - 0.00% ✗ -
Sep 16, 2024 Sep 18, 2024 Shaw Christi Director Neutral 52.5 - 0.00% ✗ -
Sep 18, 2024 Biddle Warner Weston CEO Neutral 52.5 - 0.00% ✗ -
Sep 18, 2024 Shaw Christi Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Walker Karen Marie Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
May 28, 2024 May 29, 2024 Jones Ryan Alexander CFO Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Vida Ventures, LLC 10% Owner Buy 100.0 +253,136 100.00% ✗ $5.6M
Feb 12, 2024 Feb 14, 2024 Cohen Fred E Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 SEIDENBERG BETH C Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Westlake BioPartners Fund I, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Bain Capital Life Sciences Investors, LLC 10% Owner Buy 100.0 +450,000 16.58% ✗ $9.9M
Feb 12, 2024 Feb 12, 2024 Northpond Ventures III GP, LLC Other Buy 100.0 +450,000 100.00% ✗ $9.9M
Feb 8, 2024 Liapis Stephen Constantine Director Neutral 52.5 - 0.00% ✗ -
Feb 8, 2024 Liapis Stephen Constantine Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 SPIEGELMAN DANIEL K Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Borie Dominique Christian Officer Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 CLARK IAN T Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Cohen Fred E Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Walker Karen Marie Chief Technology Officer Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Chung James Bum Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Kotzin Brian L. Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Vida Ventures, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Jones Ryan Alexander CFO Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 SEIDENBERG BETH C Director Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Maag Peter CEO Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Westlake BioPartners Fund I, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Bain Capital Life Sciences Investors, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 7, 2024 Northpond Ventures III GP, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -